Qualitative and quantitative parameters of dynamic contrast-enhanced (DCE) MRI as a diagnostic determinant of soft tissue tumor malignancy: a study from Indonesia

被引:1
|
作者
Rosida, Yulia Rosa [1 ]
Sukmaningtyas, Hermina [1 ]
Imawati, Sukma [1 ]
Prajoko, Yan Wisnu [2 ]
Sadhana, Udadi [3 ]
机构
[1] Univ Diponegoro, Fak Kedokteran, Radiol Dept, Prof Sudarto St 13, Semarang 50275, Central Java, Indonesia
[2] Univ Diponegoro, Fak Kedokteran, Surg Dept Oncol, Prof Sudarto St 13, Semarang 50275, Central Java, Indonesia
[3] Univ Diponegoro, Fak Kedokteran, Anat Pathol Dept, Prof Sudarto St 13, Semarang 50275, Central Java, Indonesia
来源
关键词
DCE; Malignancy; MRI; Soft tissue tumor; DIFFERENTIATION; PERFUSION; BENIGN; UPDATE; BREAST;
D O I
10.1186/s43055-023-01064-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundSoft tissue tumors encompass a large variety of benign and malignant lesions which are classified histologically based on the components. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a non-invasive technique that is used in differentiating benign from malignant lesions by observing the differences in the enhancement rates, index of lesion vascularity and perfusion. Therefore, this research aimed to evaluate the diagnostic efficacy of qualitative and quantitative parameters of DCE-MRI in the malignancy of soft tissue tumors.MethodsThe type of time-intensity curve (TIC), K-trans, K-ep,K- and V-e values were obtained from 30 soft tissue tumor (17 malignant and 13 benign) from patients who performed the DCE-MRI examination. The obtained values were then statistically analyzed to get the cutoff point, sensitivity, and specificity in determining the malignancy of soft tissue tumors.ResultsTIC, K-trans, and K-ep values were significantly differentiated into benign and malignant soft tissue tumors except for V-e. The TIC for benign soft tissue tumors was predominantly by type 2, while type 3, 4, and 5 were predominantly malignant. The AUC of the ROC curve demonstrated a diagnostic potential of K-trans (0.873) and K-ep (0.889). Furthermore, the cutoff point for K-trans and K-ep was 0.2905 and 0.3365 with a sensitivity of 88.2% and 94.1%, specificity of 84.6%, PPV of 88.2% and 88.9%, and NPV of 84.6%, and 91.7%.ConclusionsQualitative and quantitative parameters of DCE-MRI helped diagnose soft tissue tumor malignancy with a cutoff point for K-trans 0.2905 and K-ep 0.3365.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy
    Ziayee, F.
    Mueller-Lutz, A.
    Gross, J.
    Quentin, M.
    Ullrich, T.
    Heusch, P.
    Arsov, C.
    Rabenalt, R.
    Albers, P.
    Antoch, G.
    Wittsack, H. J.
    Schimmoeller, L.
    MAGNETIC RESONANCE IMAGING, 2018, 53 : 28 - 33
  • [42] Sorafenib (S) with preoperative chemoradiotherapy for extremity soft tissue sarcomas (STS) and evaluation by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
    Perlewitz, K. S.
    Huang, W.
    Hayden, J. B.
    Adler, Z. B.
    Hung, A.
    Mansoor, A.
    Holtorf, M. L.
    Hemmington, S. L.
    Woodward, W. J.
    Ryan, C. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Quantitative dynamic contrast-enhanced (DCE) MRI radiomic phenotypes for prediction of nodal and distal metastasis in breast cancer patients
    Rauch, Gaiane Margishvili
    Drukker, Karen
    Elshafeey, Nabil
    Mohamed, Rania M. M.
    Boge, Medina
    Adrada, Beatriz E.
    Candelaria, Rosalind P.
    Salama, Mo
    Shkatova, Irene
    Giger, Maryellen
    Yang, Wei T.
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules
    Fan, Jinfang
    Tao, Lingling
    Zhan, Weiwei
    Li, Weiwei
    Kuang, Lijun
    Zhao, Yingyan
    Zhou, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [45] Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
    Louke J. Delrue
    Veerle Casneuf
    Nancy Van Damme
    Peter Blanckaert
    Marc Peeters
    Wim P. Ceelen
    Philippe C. O. Duyck
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2011, 24 : 225 - 232
  • [46] Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
    Delrue, Louke J.
    Casneuf, Veerle
    Van Damme, Nancy
    Blanckaert, Peter
    Peeters, Marc
    Ceelen, Wim P.
    Duyck, Philippe C. O.
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2011, 24 (04): : 225 - 232
  • [47] Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas
    Nguyen, T. B.
    Cron, G. O.
    Bezzina, K.
    Perdrizet, K.
    Torres, C. H.
    Chakraborty, S.
    Woulfe, J.
    Jansen, G. H.
    Thornhill, R. E.
    Zanette, B.
    Cameron, I. G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (12) : 2217 - 2223
  • [48] Quantitative evaluation of dynamic glymphatic activity in insomnia: A contrast-enhanced synthetic MRI study
    Xiong, Ruifang
    Feng, Jie
    Zhu, Hanting
    Li, Chengyi
    Hu, Pengxin
    Zou, Yu
    Zhou, Mingyu
    Wang, Ye
    Tang, Xiaoping
    SLEEP MEDICINE, 2025, 127 : 16 - 23
  • [49] Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?
    Bahri, S.
    Chen, J. -H.
    Yu, H. J.
    Kuzucan, A.
    Nalcioglu, O.
    Su, M. -Y.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 822 - U2
  • [50] A comparative study between the diagnostic performance of contrast-enhanced digital mammography and dynamic contrast-enhanced MRI in invasive lobular carcinoma of the breast
    Sherihan Fakhry
    Rasha Mohamed Kamal
    Omnia Mokhtar Nada
    Amira Emad Abo El Enien Mohamed
    Mennatallah Mohamed Hanafy
    Egyptian Journal of Radiology and Nuclear Medicine, 55